Welcome to our dedicated page for Weed news (Ticker: BUDZ), a resource for investors and traders seeking the latest updates and insights on Weed stock.
WEED Inc. (OTCQB: BUDZ) generates a steady flow of news as a global cannabis and hemp bioresearch company based in the United States. Company communications emphasize work on cannabis-derived compounds for human and animal health, rare landrace genetics, hemp licensing in Arizona and international subsidiaries in Israel and Australia. The BUDZ news feed on Stock Titan brings together these disclosures so readers can follow how the business and its research-focused strategy evolve over time.
Recent announcements describe WEED Inc.’s plans to expand into consumer packaged goods using its landrace strains, industrial hemp operations through HEMP BioSciences Inc., and the buildout of a cGMP-certified kitchen for hemp-derived products. Other releases highlight the acquisition of Hempirical Genetics LLC, adding hundreds of proprietary cannabis and hemp strains, and the company’s exit from the Colorado cannabis marketplace to reallocate resources toward Arizona and other priorities.
Another notable theme in WEED Inc. news is its emphasis on intellectual property and branding, including registered marks for WEED and Panama Red, and trademark efforts related to names such as ACAPULCO GOLD and WEED Rules!. The company also reports on clinical trial ambitions in Israel and Australia through WEED Israel (Cannabis) Ltd. and WEED Australia Ltd., as well as conference participation and regulatory milestones under Australian and U.S. frameworks.
More recent coverage introduces WEED Inc.’s AI, crypto and blockchain initiatives through a strategic partnership with Remergify Inc. to develop WEEDCoin and BUDZCoin, and to tokenize its cannabis genetics via NFTs. By reviewing the BUDZ news page, readers can see how WEED Inc. presents its research agenda, licensing developments, IP strategy and emerging digital-asset plans in one consolidated stream.
WEED, Inc. (OTCQB:BUDZ) announced plans to develop the Sugar Hill Golf Course in Westfield, NY into a luxury cannabis-friendly resort. Having recently completed a purchase of the property for ~$250,000, which was appraised at $1.9 million, they aim to establish a cannabis research division and luxury condos. Future ambitions include edibles and beverage research. The company intends to form a New York division to expand R&D programs and has budgeted $40 million for various initiatives, though no funds have been raised yet for the resort project.
WEED, Inc. (OTCQB:BUDZ) has acquired the Sugar Hill Golf Course for approximately $250,000, significantly lower than its 2019 appraisal value of $1.9 million. The company plans to develop a new division for infused beverages and edibles in New York, leveraging the property’s unlimited water extraction rights. Additionally, WEED aims to expand its R&D programs globally, focusing on cannabinoid strains and clinical trials. Despite ambitious plans, potential investors are cautioned about the significant legal risks associated with cannabis operations in the U.S.
WEED, Inc. (OTCQB:BUDZ) announced the formation of HEMP BioSciences Inc., aimed at expanding R&D in cannabis and hemp markets. CEO Glenn E. Martin emphasized the company's potential for growth, particularly through developing advanced CBD, CBN, and CBG strains. The new division will focus on both pharmaceutical and non-pharmaceutical products for global distribution. WEED's subsidiaries operate in several countries, including Australia and Israel, preparing for clinical trials aimed at enhancing women's health and treating PTSD.
WEED, Inc. (OTCQB:BUDZ) announced its upcoming presentation at Starlight Capital's virtual conference on March 25, 2021, where CEO Glenn E. Martin will unveil a new $40 million financing round under Regulation A. The company focuses on expanding its cannabis and hemp bioresearch initiatives globally. Martin highlighted opportunities for investors to participate in WEED's growth, emphasizing the company's plans post-COVID and its R&D partnerships in Australia, Israel, and Hong Kong. The offering aims to democratize investment in the cannabis market.
WEED, Inc. (BUDZ) has announced a new $40 million financing round under Regulation A, Tier 2, as qualified by the SEC. The company aims to expand its global R&D efforts and plans to acquire domestic and foreign cannabis-related assets. With subsidiaries in Australia, Israel, and Hong Kong, WEED is targeting growth in both pharmaceutical and non-pharmaceutical sectors. The offering consists of 40 million units at $1.00 each, including warrants for additional shares. The company emphasizes the potential benefit of increased public participation in the cannabis market.